RedHill Biopharma Announces New European and Japanese Patents for Talicia®

    NEXT STORY
    Novo Nordisk: Ozempic® superior in lowering blood sugar and weight vs placebo, both in combination with SGLT-2 inhibitors
    PREV STORY
    Translate Bio to Present at the 39th Annual Cowen and Company Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sandoz proposed biosimilars rituximab and etanercept recommended for approval in Europe*

    Sandoz receives positive CHMP opinions for biosimilars rituximab and etanercept to treat immunological diseases.  ...

    author_avatar
    NASDAQ Market News

    Strongbridge Biopharma plc Announces Executive Promotion and Leadership Transition

    DUBLIN, Ireland and TREVOSE, Pa., June 09, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc ...

    author_avatar
    NASDAQ Market News

    argenx announces pipeline expansion and “argenx 2021” vision to build integrated immunology company at 2019 R&D Day

    author_avatar
    NASDAQ Market News